We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous Sclerosis

News   May 24, 2018 | Original story from University of Texas Health

 
Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous Sclerosis

Working on a promising treatment for facial tumors tied to tuberous sclerosis complex, from the left, are Adelaide Hebert, M.D.; John Slopis, M.D.; Mary Kay Koenig, M.D.; Joshua Samuels, M.D., M.P.H.; and Hope Northrup, M.D. All are from McGovern Medical School at UTHealth in Houston with the exception of Slopis, who is with The University of Texas MD Anderson Cancer Center. Credit: Maricruz Kwon, UTHealth

 
 
 

RELATED ARTICLES

The Power of Genetic Testing – Picking Out the Best Drugs for Children With Cancer

News

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

READ MORE

A Potential Drug Target for Diabetic Retinopathy

News

Approximately one in three diabetic patients develops diabetic retinopathy (DR), which can cause visual impairment and eventual blindness. Now researchers have discovered that high glucose increases the levels of enzymatic precursor, called lysyl oxidase propeptide (LOX-PP), that promotes cell death which could be a potential target for treating DR.

READ MORE

Team Discover Protein That Hampers Bone Healing

News

Scientists have discovered that a certain protein, which is more prevalent in older people, interferes with bone healing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE